Infugem Prices, Coupons, Copay Cards & Patient Assistance
Infugem (gemcitabine) is a member of the antimetabolites drug class and is commonly used for Breast Cancer, Breast Cancer - Metastatic, Non Small Cell Lung Cancer, and others.
Infugem prices
Intravenous Solution
10 mg/mL-NaCl 0.9% Infugem intravenous solution from $489.67 for 120 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 120 milliliters | $4.08 | $489.67 |
| 130 milliliters | $4.07 | $529.68 |
| 140 milliliters | $4.07 | $569.70 |
| 150 milliliters | $4.06 | $609.71 |
| 160 milliliters | $4.06 | $649.72 |
| 170 milliliters | $4.06 | $689.74 |
| 180 milliliters | $4.05 | $729.75 |
| 190 milliliters | $4.05 | $769.77 |
| 200 milliliters | $4.05 | $809.78 |
| 220 milliliters | $4.04 | $889.81 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Infugem Coupons, Copay Cards and Rebates
Infugem offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Infugem
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Infugem (gemcitabine) Injection for Intravenous use
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Infugem (gemcitabine) Injection for Intravenous use
More information please phone: 866-316-7263 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Fluorouracil
Fluorouracil is used for anal cancer, breast cancer, breast cancer, palliative, cancer, cervical ...
Capecitabine
Capecitabine is used for anal cancer, breast cancer, breast cancer, metastatic, colorectal cancer ...
More about Infugem (gemcitabine)
- Infugem consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español